trending Market Intelligence /marketintelligence/en/news-insights/trending/C0jXsg2fik-s2jLawlU6eQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

PRA Health Sciences to take over Symphony Health Solutions for $530M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


PRA Health Sciences to take over Symphony Health Solutions for $530M

PRA Health Sciences Inc. agreed to acquire Symphony Health Solutions Corp. for an up-front cash payment of $530 million.

Symphony Health Solutions is a privately held provider of data, analytics and consulting solutions to the life sciences market. It is owned by technology investment firm Symphony Technology Group.

The payment is subject to customary purchase price adjustments and potential contingent payments that are based on Symphony Health exceeding financial targets for the 12-month periods ending December 2017 and December 2018.

PRA Health said the transaction is expected to be immediately accretive to its adjusted net income per share. The company has also entered into debt financing commitments with PNC Bank for amounts that are enough to provide funds necessary to complete the transaction.

Neal Bibeau will continue to serve as CEO of Symphony Health.

The deal is expected to close in the third quarter, subject to regulatory clearances in the U.S. and other customary closing conditions.

Jefferies LLC is acting as exclusive financial adviser to PRA Health, and Simpson Thacher & Bartlett LLP is serving as its legal counsel. Blank Rome LLP is Symphony Health's legal counsel.